The Clinical Observation Of Mahuangfuzixixin Decoction Treated On Wheezi Ng In Infants Of Yang Deficiency And Phlegm Type

Objective:This project aims to use Mahuangfuzixixin decoction, and treatment of wheezing infants for yang. An objective evaluation the clinical efficacy of the wheezing infants to use Mahuangfuzixixin decoction,and relatively yang drinking laws and the advantages and disadvantages of the conventional treatment. Provide a scientific basis for the wen yang treatment of wheezing infants.Method:In this study used controlled experiments. The test objects are0-3years old children of infants and asthmatic with wheezing. Outpatient income children into the treatment group, according to children’s age and the severity. Over the same period in the inpatient department, income of age and condition where children matching corresponds to the control group. Age segment stratified by size:the young age (0month<age≤6month), the old age (6month<age≤3years). Ultimate collection of the treatment group and control group of30cases, the(0month<age≤6month) and (6month <age≤3years) in each group of15cases. The Treatment group to use Mahuangfuzixixin decoction in7days with addition and subtraction, and the control group to use antispasmodic asthma phlegm treatment in7days. After treatment, children with0,4,7days of clinical symptoms, physical signs, and1week after treatment follow-up. Evaluation of the clinical efficacy with Mahuangfuzixixin decoction.Results:In the overall clinical efficacy, efficacy between the treatment group and control group showed no significant difference (P=0.731P>0.05). In the overall breathing control, breathing control the situation between the two groups showed no significant difference (P=0.173P>0.05). From the ages, the clinical efficacy of older (P=0.157P>0.05) and the breathing control (P=0.363P>0.05), prove that the old age with the treatment group and control group was no significant difference in clinical efficacy and breathing control. The young age of the clinical signs efficacy (P=1.00P>0.05), no significant difference between the two groups. But the breathing control comparison (P=0.037P<0.05), have the statistically significant. Prove that breathing control compared to the situation in the young age between the two groups significantly different, and the treatment group was significantly better than the control group. Analysis of single symptoms, significant difference between the two groups of the throat phlegm improve the situation. Mahuangfuzixixin decoction to improve the symptoms of throat phlegm significantly better than western medicine in young age children group.Conclusion:1. Treatment of wheezing infants with Mahuangfuzixixin decoction, the clinical efficacy was no significant difference with the conventional western medicine.2. The young age children with breathing control, Mahuangfuzixixin decoction is better than conventional western medicine.3. Mahuangfuzixixin decoction to improve the symptoms of throat phlegm significantly better than western medicine in young age children group.